Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Akiko Popiel

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|March 19, 2013
Inhibition of protein misfolding/aggregation using polyglutamine binding peptide QBP1 as a therapy for the polyglutamine diseasesH Akiko Popiel, Toshihide Takeuchi, James R Burke, et al.
Bioorganic & Medicinal Chemistry|January 6, 2009
Structure-activity relationship study on polyglutamine binding peptide QBP1Kenji Tomita, H Akiko Popiel, Yoshitaka Nagai, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 29, 2015
Intercellular chaperone transmission via exosomes contributes to maintenance of protein homeostasis at the organismal levelToshihide Takeuchi, Mari Suzuki, Nobuhiro Fujikake, et al.
Nature Structural & Molecular Biology|March 21, 2007
A toxic monomeric conformer of the polyglutamine proteinYoshitaka Nagai, Takashi Inui, H Akiko Popiel, et al.
Journal of Amino Acids|February 8, 2012
The Aggregation Inhibitor Peptide QBP1 as a Therapeutic Molecule for the Polyglutamine Neurodegenerative DiseasesH Akiko Popiel, James R Burke, Warren J Strittmatter, et al.
Plos One|December 11, 2012
Hsp40 gene therapy exerts therapeutic effects on polyglutamine disease mice via a non-cell autonomous mechanismH Akiko Popiel, Toshihide Takeuchi, Hiromi Fujita, et al.
The Journal of Biological Chemistry|December 7, 2014
p62 plays a protective role in the autophagic degradation of polyglutamine protein oligomers in polyglutamine disease model fliesYuji Saitoh, Nobuhiro Fujikake, Yuma Okamoto, et al.
Molecular Therapy. Nucleic Acids|June 3, 2018
Supplemental Treatment for Huntington's Disease with miR-132 that Is Deficient in Huntington's Disease BrainMasashi Fukuoka, Masaki Takahashi, Hiromi Fujita, et al.
Eneuro|April 5, 2017
Transgenic Monkey Model of the Polyglutamine Diseases Recapitulating Progressive Neurological SymptomsIkuo Tomioka, Hidetoshi Ishibashi, Eiko N Minakawa, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|March 19, 2013
Inhibition of protein misfolding/aggregation using polyglutamine binding peptide QBP1 as a therapy for the polyglutamine diseasesH Akiko Popiel, Toshihide Takeuchi, James R Burke, et al.
Bioorganic & Medicinal Chemistry|January 6, 2009
Structure-activity relationship study on polyglutamine binding peptide QBP1Kenji Tomita, H Akiko Popiel, Yoshitaka Nagai, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 29, 2015
Intercellular chaperone transmission via exosomes contributes to maintenance of protein homeostasis at the organismal levelToshihide Takeuchi, Mari Suzuki, Nobuhiro Fujikake, et al.
Nature Structural & Molecular Biology|March 21, 2007
A toxic monomeric conformer of the polyglutamine proteinYoshitaka Nagai, Takashi Inui, H Akiko Popiel, et al.
Journal of Amino Acids|February 8, 2012
The Aggregation Inhibitor Peptide QBP1 as a Therapeutic Molecule for the Polyglutamine Neurodegenerative DiseasesH Akiko Popiel, James R Burke, Warren J Strittmatter, et al.
Plos One|December 11, 2012
Hsp40 gene therapy exerts therapeutic effects on polyglutamine disease mice via a non-cell autonomous mechanismH Akiko Popiel, Toshihide Takeuchi, Hiromi Fujita, et al.
The Journal of Biological Chemistry|December 7, 2014
p62 plays a protective role in the autophagic degradation of polyglutamine protein oligomers in polyglutamine disease model fliesYuji Saitoh, Nobuhiro Fujikake, Yuma Okamoto, et al.
Molecular Therapy. Nucleic Acids|June 3, 2018
Supplemental Treatment for Huntington's Disease with miR-132 that Is Deficient in Huntington's Disease BrainMasashi Fukuoka, Masaki Takahashi, Hiromi Fujita, et al.
Eneuro|April 5, 2017
Transgenic Monkey Model of the Polyglutamine Diseases Recapitulating Progressive Neurological SymptomsIkuo Tomioka, Hidetoshi Ishibashi, Eiko N Minakawa, et al.
Pageof 2